EA026380B1 - Соединения хроманов - Google Patents

Соединения хроманов Download PDF

Info

Publication number
EA026380B1
EA026380B1 EA201492271A EA201492271A EA026380B1 EA 026380 B1 EA026380 B1 EA 026380B1 EA 201492271 A EA201492271 A EA 201492271A EA 201492271 A EA201492271 A EA 201492271A EA 026380 B1 EA026380 B1 EA 026380B1
Authority
EA
Eurasian Patent Office
Prior art keywords
compound
dimethyldispiro
amino
mixture
carboxamide
Prior art date
Application number
EA201492271A
Other languages
English (en)
Russian (ru)
Other versions
EA201492271A1 (ru
Inventor
Ресуке Мунаката
Макото Иноуе
Хироаки Томинага
Синго Ямасаки
Ясухиро Сиина
Кийохиро Самидзу
Хисао Хамагути
Линь Хун
Original Assignee
Коментис, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Коментис, Инк. filed Critical Коментис, Инк.
Publication of EA201492271A1 publication Critical patent/EA201492271A1/ru
Publication of EA026380B1 publication Critical patent/EA026380B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
EA201492271A 2012-05-30 2013-05-29 Соединения хроманов EA026380B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261653321P 2012-05-30 2012-05-30
US201361782038P 2013-03-14 2013-03-14
PCT/US2013/043016 WO2013181202A2 (en) 2012-05-30 2013-05-29 Chromane compounds

Publications (2)

Publication Number Publication Date
EA201492271A1 EA201492271A1 (ru) 2015-10-30
EA026380B1 true EA026380B1 (ru) 2017-04-28

Family

ID=49674034

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201492271A EA026380B1 (ru) 2012-05-30 2013-05-29 Соединения хроманов

Country Status (15)

Country Link
US (2) US8975415B2 (enExample)
EP (1) EP2854797A4 (enExample)
JP (1) JP2015518048A (enExample)
KR (1) KR20150023536A (enExample)
CN (1) CN104394862A (enExample)
AR (1) AR091203A1 (enExample)
AU (1) AU2013267555A1 (enExample)
BR (1) BR112014029597A2 (enExample)
CA (1) CA2873678A1 (enExample)
EA (1) EA026380B1 (enExample)
HK (1) HK1208817A1 (enExample)
MX (1) MX2014014066A (enExample)
SG (1) SG11201407796YA (enExample)
TW (1) TW201408672A (enExample)
WO (1) WO2013181202A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013181202A2 (en) 2012-05-30 2013-12-05 Astellas Pharma Inc. Chromane compounds
UY36347A (es) * 2014-10-07 2016-04-01 Astrazeneca Ab Compuestos y su uso como inhibidores de bace
CN110818694B (zh) * 2019-11-18 2023-04-21 上海医药工业研究院有限公司 艾拉普林中间体及其应用
CN110724135B (zh) * 2019-11-18 2023-04-28 上海医药工业研究院有限公司 一种艾拉普林中间体及其制备方法
CN110790753B (zh) * 2019-11-18 2023-04-07 上海医药工业研究院 艾拉普林对甲苯磺酸盐、其制备方法和应用
CN110713483B (zh) * 2019-11-18 2023-04-07 上海医药工业研究院 艾拉普林中间体及艾拉普林的制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100087429A1 (en) * 2008-09-11 2010-04-08 Amgen Inc. Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use
WO2011072064A1 (en) * 2009-12-08 2011-06-16 Array Biopharma Inc. S piro [chroman - 4, 4 ' - imidazol] ones as beta - secretase inhibitors
US20110152253A1 (en) * 2008-07-28 2011-06-23 Eisai R&D Management Co., Ltd Spiroaminodihydrothiazine derivatives
US20110218192A1 (en) * 2008-08-19 2011-09-08 Vitae Pharmaceuticals, Inc. Inhibitors Of Beta-Secretase
US20120065195A1 (en) * 2010-03-31 2012-03-15 Clark Christopher T Compounds for treating neurodegenerative diseases

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1196609A2 (en) 1999-06-28 2002-04-17 Oklahoma Medical Research Foundation Catalytically active recombinant memapsin and methods of use thereof
US20040121947A1 (en) 2000-12-28 2004-06-24 Oklahoma Medical Research Foundation Compounds which inhibit beta-secretase activity and methods of use thereof
EP1448218A4 (en) 2001-10-23 2009-01-14 Oklahoma Med Res Found BETA SECRETASE INHIBITORS AND METHODS OF USE
US7700603B2 (en) 2003-12-15 2010-04-20 Schering Corporation Heterocyclic aspartyl protease inhibitors
CA2548388A1 (en) 2003-12-15 2005-06-30 Schering Corporation Heterocyclic aspartyl protease inhibitors
WO2007100536A1 (en) 2006-02-24 2007-09-07 Wyeth DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
WO2010013302A1 (ja) * 2008-07-28 2010-02-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 スピロアミノジヒドロチアジン誘導体
JP5444240B2 (ja) * 2008-07-28 2014-03-19 エーザイ・アール・アンド・ディー・マネジメント株式会社 スピロアミノジヒドロチアジン誘導体
PT2406240E (pt) * 2009-03-13 2016-02-24 Boehringer Ingelheim Int Inibidores de beta-secretase
US8461160B2 (en) 2009-05-08 2013-06-11 Hoffmann-La Roche, Inc. Dihydropyrimidinones
CN102812005B (zh) * 2010-02-24 2014-12-10 生命医药公司 β-分泌酶抑制剂
ES2450568T3 (es) * 2010-03-15 2014-03-25 Amgen Inc. Compuestos espiero de amino-dihidrooxazina y amino-dihidrotiazina como moduladores de beta-secretasa y su uso médico
CA2791281A1 (en) * 2010-03-15 2011-09-22 Amgen Inc. Spiro-tetracyclic ring compounds as beta-secretase modulators
WO2011130741A1 (en) 2010-04-16 2011-10-20 Array Biopharma Inc. Compounds for treating neurodegenerative diseases
UY33627A (es) 2010-09-24 2013-04-30 Array Biopharma Inc Compuestos para tratar enfermedades neurodegenerativas
TW201300380A (zh) 2010-10-19 2013-01-01 Comentis Inc 抑制β－分泌酶活性之噁二唑化合物及其使用方法
US20120157448A1 (en) 2010-11-22 2012-06-21 Adam Cook Compounds for treating neurodegenerative diseases
EP2643325A1 (en) 2010-11-23 2013-10-02 Amgen Inc. Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use
US8415483B2 (en) 2010-12-22 2013-04-09 Astrazeneca Ab Compounds and their use as BACE inhibitors
US9346827B2 (en) 2011-02-07 2016-05-24 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use
WO2012112462A1 (en) 2011-02-15 2012-08-23 Amgen Inc. Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use
US9079919B2 (en) 2011-05-27 2015-07-14 Hoffmann-La Roche Inc. Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as BACE1 and/or BACE2 inhibitors
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
EP2780321B1 (en) 2011-10-10 2015-12-30 Astrazeneca AB Mono-fluoro beta-secretase inhibitors
WO2013181202A2 (en) 2012-05-30 2013-12-05 Astellas Pharma Inc. Chromane compounds
EP2669286A1 (en) 2012-05-31 2013-12-04 Ares Trading S.A. Spiro tetrahydro-benzothiophen derivatives useful for the treatment of neurodegenerative diseases

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110152253A1 (en) * 2008-07-28 2011-06-23 Eisai R&D Management Co., Ltd Spiroaminodihydrothiazine derivatives
US20110218192A1 (en) * 2008-08-19 2011-09-08 Vitae Pharmaceuticals, Inc. Inhibitors Of Beta-Secretase
US20100087429A1 (en) * 2008-09-11 2010-04-08 Amgen Inc. Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use
WO2011072064A1 (en) * 2009-12-08 2011-06-16 Array Biopharma Inc. S piro [chroman - 4, 4 ' - imidazol] ones as beta - secretase inhibitors
US20120065195A1 (en) * 2010-03-31 2012-03-15 Clark Christopher T Compounds for treating neurodegenerative diseases

Also Published As

Publication number Publication date
TW201408672A (zh) 2014-03-01
AR091203A1 (es) 2015-01-21
US20140179695A1 (en) 2014-06-26
CA2873678A1 (en) 2013-12-05
HK1208817A1 (en) 2016-03-18
EP2854797A2 (en) 2015-04-08
WO2013181202A2 (en) 2013-12-05
KR20150023536A (ko) 2015-03-05
JP2015518048A (ja) 2015-06-25
MX2014014066A (es) 2015-03-19
WO2013181202A3 (en) 2014-01-30
SG11201407796YA (en) 2014-12-30
CN104394862A (zh) 2015-03-04
AU2013267555A1 (en) 2014-12-04
EA201492271A1 (ru) 2015-10-30
US20150225386A1 (en) 2015-08-13
US8975415B2 (en) 2015-03-10
US9242973B2 (en) 2016-01-26
EP2854797A4 (en) 2016-01-13
BR112014029597A2 (pt) 2017-11-07

Similar Documents

Publication Publication Date Title
ES3039586T3 (en) Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
CN109422752B (zh) 一类具有抑制并降解布鲁顿酪氨酸蛋白激酶Btk活性的化合物
KR102565224B1 (ko) Jak 패밀리의 키나제의 억제제로서의 이미다조피롤로피리딘
RU2684324C1 (ru) Бициклические конденсированные гетероарильные или арильные соединения в качестве модуляторов IRAK4
EA026380B1 (ru) Соединения хроманов
CA3191842A1 (en) Protein tyrosine phosphatase inhibitors and methods of use thereof
JP6126319B1 (ja) （６Ｓ，９ａＳ）−Ｎ−ベンジル−６−［（４−ヒドロキシフェニル）メチル］−４，７−ジオキソ−８−（｛６−［３−（ピペラジン−１−イル）アゼチジン−１−イル］ピリジン−２−イル｝メチル）−２−（プロプ−２−エン−１−イル）−オクタヒドロ−１Ｈ−ピラジノ［２，１−ｃ］［１，２，４］トリアジン−１−カルボキサミド化合物の結晶
BR112015012571A2 (pt) compostos de imidazopiridina
IL279428B1 (en) Pyridinyl and pyrazinyl -(aza)indolesulfonamides
EA009457B1 (ru) Бензимидазолоновые соединения, обладающие агонистической активностью в отношении 5-нтрецепторов
EA025402B1 (ru) Азаиндолы в качестве противовирусных агентов против респираторного синцитиального вируса
WO2013138753A1 (en) Prodrugs of riluzole and their method of use
CA2924705A1 (en) Quinazoline derivative and preparation method therefor
EP4574827A1 (en) Nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof, preparation method therefor, and the use thereof
EA024201B1 (ru) Ингибиторы вируса гепатита с
WO2020224652A1 (zh) 一类泛素化特异性蛋白酶抑制剂及其制备方法与应用
US20140031340A1 (en) 5-Amino-Oxazepine and 5-Amino-Thiazepane Compounds as Beta Secretase Antagonists and Methods of Use
JP2019504016A (ja) アルキルジヒドロキノリンスルホンアミド化合物
WO2013192610A2 (en) Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis
BR112019017003A2 (pt) antibióticos macrocíclicos de amplo espectro
CN111377873B (zh) 氨基嘧啶化合物及其制备方法和用途
EP3487859A1 (en) ANTIMETASTATIC 2H-SELENOPHENO[3,2-h]CHROMENES, SYNTHESIS THEREOF, AND METHODS OF USING SAME AGENTS
TW202126638A (zh) Bet分解劑
EA023039B1 (ru) Бензазепиновое соединение, фармацевтическая композиция, включающая его, и его применение
EP3036219A2 (en) Novel beta lactams as modulators of glutamate uptake and methods for use thereof

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU